Report cover image

Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20385069

Description

Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on real-time pcr, digital pcr and end-point pcr market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for real-time pcr, digital pcr and end-point pcr ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The real-time pcr, digital pcr and end-point pcr market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product: Instruments; Consumables And Reagents; Software And Services

2) By Technology: Quantitative; End-Point Polymerase Chain Reaction (PCR); Digital

3) By Applications: Clinical; Research; Forensic; Other Applications

4) By End User: Hospital; Diagnostic Labs; Pharma; Biotech; Contract Research Organizations

Subsegments:

1) By Instruments: Real-Time PCR Systems; Digital PCR Systems; End-Point PCR Systems

2) By Consumables And Reagents: PCR Plates And Tubes; Primers And Probes; PCR Master Mix; DNA Polymerases And Nucleotides

3) By Software And Services: Analysis Software; Data Management Software; Calibration And Maintenance Services; Training And Support Services

Companies Mentioned: F. Hoffmann La Roche Ltd.; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Co.; GE HealthCare Technologies Inc.; Agilent Technologies Inc.; bioMérieux S.A.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Eppendorf Group; Promega Corporation; Meridian Bioscience Inc.; Takara Bio Inc. ; Cole-Parmer Instrument Company LLC; Bioneer Corporation; Enzo Life Sciences Inc.; Analytik Jena AG ; Fluidigm Corporation; Elitech Group SAS; Microsynth AG; Stilla Technologies SAS; HTG Molecular Diagnostics Inc.; AITbiotech Pte Ltd.; Bio Molecular Systems; JN Medsys Pte Ltd.; Biomeme Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Pulmonary Embolism Market Characteristics
3. Pulmonary Embolism Market Trends And Strategies
4. Pulmonary Embolism Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Pulmonary Embolism Growth Analysis And Strategic Analysis Framework
5.1. Global Pulmonary Embolism PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pulmonary Embolism Market Growth Rate Analysis
5.4. Global Pulmonary Embolism Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pulmonary Embolism Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pulmonary Embolism Total Addressable Market (TAM)
6. Pulmonary Embolism Market Segmentation
6.1. Global Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medications
Mechanical Devices
Other Treatments
6.2. Global Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chest X-Ray
Electrocardiogram (ECG)
Magnetic Resonance Imaging (MRI)
Computed Tomography Scan
Pulmonary Angiography
Venography
Venous Ultrasound
D-Dimer Test
Other Diagnosis
6.3. Global Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Shortness Of Breath
Chest Pain
Cough
Irregular Heartbeat
Dizziness
Fever
Cyanosis
Other Symptoms
6.4. Global Pulmonary Embolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other Distribution Channels
6.5. Global Pulmonary Embolism Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Homecare
Other End-Users
6.6. Global Pulmonary Embolism Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anticoagulants
Thrombolytics
6.7. Global Pulmonary Embolism Market, Sub-Segmentation Of Mechanical Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inferior Vena Cava (IVC) Filters
Catheter-Assisted Thrombectomy
6.8. Global Pulmonary Embolism Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgical Embolectomy
Supportive Care
7. Pulmonary Embolism Market Regional And Country Analysis
7.1. Global Pulmonary Embolism Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pulmonary Embolism Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Pulmonary Embolism Market
8.1. Asia-Pacific Pulmonary Embolism Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Pulmonary Embolism Market
9.1. China Pulmonary Embolism Market Overview
9.2. China Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Pulmonary Embolism Market
10.1. India Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Pulmonary Embolism Market
11.1. Japan Pulmonary Embolism Market Overview
11.2. Japan Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Pulmonary Embolism Market
12.1. Australia Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Pulmonary Embolism Market
13.1. Indonesia Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Pulmonary Embolism Market
14.1. South Korea Pulmonary Embolism Market Overview
14.2. South Korea Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Pulmonary Embolism Market
15.1. Western Europe Pulmonary Embolism Market Overview
15.2. Western Europe Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Pulmonary Embolism Market
16.1. UK Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Pulmonary Embolism Market
17.1. Germany Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Pulmonary Embolism Market
18.1. France Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Pulmonary Embolism Market
19.1. Italy Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Pulmonary Embolism Market
20.1. Spain Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Pulmonary Embolism Market
21.1. Eastern Europe Pulmonary Embolism Market Overview
21.2. Eastern Europe Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Pulmonary Embolism Market
22.1. Russia Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Pulmonary Embolism Market
23.1. North America Pulmonary Embolism Market Overview
23.2. North America Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Pulmonary Embolism Market
24.1. USA Pulmonary Embolism Market Overview
24.2. USA Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Pulmonary Embolism Market
25.1. Canada Pulmonary Embolism Market Overview
25.2. Canada Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Pulmonary Embolism Market
26.1. South America Pulmonary Embolism Market Overview
26.2. South America Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Pulmonary Embolism Market
27.1. Brazil Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Pulmonary Embolism Market
28.1. Middle East Pulmonary Embolism Market Overview
28.2. Middle East Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Pulmonary Embolism Market
29.1. Africa Pulmonary Embolism Market Overview
29.2. Africa Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Pulmonary Embolism Market Competitive Landscape And Company Profiles
30.1. Pulmonary Embolism Market Competitive Landscape
30.2. Pulmonary Embolism Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson and Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Merck And Co.Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Pulmonary Embolism Market Other Major And Innovative Companies
31.1. Bayer AG
31.2. Sanofi S.A.
31.3. Bristol Myers Squibb Company
31.4. GSK plc
31.5. Abbott Laboratories
31.6. AstraZeneca plc
31.7. Medtronic plc
31.8. Eli Lilly and Company
31.9. Gilead Sciences Inc.
31.10. Baxter International Inc.
31.11. Teva Pharmaceutical Industries Ltd.
31.12. Regeneron Pharmaceuticals Inc.
31.13. Mylan N.V.
31.14. Daiichi Sankyo Co. Ltd.
31.15. Boehringer Ingelheim International GmbH
32. Global Pulmonary Embolism Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Pulmonary Embolism Market
34. Recent Developments In The Pulmonary Embolism Market
35. Pulmonary Embolism Market High Potential Countries, Segments and Strategies
35.1 Pulmonary Embolism Market In 2029 - Countries Offering Most New Opportunities
35.2 Pulmonary Embolism Market In 2029 - Segments Offering Most New Opportunities
35.3 Pulmonary Embolism Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.